Itching relief drug trial for dialysis patients halted early
NCT ID NCT04393675
First seen Feb 12, 2026 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This study tested a new drug called LT5001 to see if it is safe and how it works in people on dialysis who suffer from severe itching. The trial was stopped early and included 18 adults aged 20 to 75. The main goal was to check for side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UREMIC PRURITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China Medical University Hospital
Taichung, Taiwan
Conditions
Explore the condition pages connected to this study.